SWM
RGNX icon

Spire Wealth Management’s Regenxbio RGNX Stock Holding History

Spire Wealth Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98K Hold
750
– – ﹤0.01% 1680
2026
Q1 		$6.29K Buy
750
+250
+50% +$2.63K ﹤0.01% 1773
2025
Q4 		$7.2K Buy
+500
New +$6.23K ﹤0.01% 1822
2022
Q3 		– Sell
-200
Closed -$5K – 2525
2022
Q2 		$5K Sell
200
-200
-50% -$5K ﹤0.01% 2145
2022
Q1 		$13K Hold
400
– – ﹤0.01% 1957
2021
Q4 		$13K Hold
400
– – ﹤0.01% 2286
2021
Q3 		$17K Hold
400
– – ﹤0.01% 1928
2021
Q2 		$16K Hold
400
– – ﹤0.01% 1969
2021
Q1 		$14K Buy
+400
New +$17.1K ﹤0.01% 2305

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Spire Wealth Management's RGNX Position: Q2 2026 in Review

Spire Wealth Management held its Regenxbio (RGNX) position steady in Q2 2026 at 750 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Spire Wealth Management first reported a position in RGNX in Q1 2021 and has held it in 9 quarters since. The position peaked at $17K in Q3 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Spire Wealth Management held 750 shares of Regenxbio worth $8.98K as of Q2 2026.
  • Spire Wealth Management left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1680 holding.
  • Spire Wealth Management first reported a position in Regenxbio in Q1 2021 and has held it in 9 quarters since.
  • Spire Wealth Management's Regenxbio position peaked at $17K in Q3 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.